Caitong International Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.78K Buy
1,092
+1,082
+10,820% +$9.69K 0.01% 734
2025
Q1
$75 Buy
+10
New +$75 ﹤0.01% 2004